Immorna Biotherapeutics Expands Its R&D Footprint in RTP, NC and Appoints Key Senior Scientific Leaders
/PRNewswire/ -- Immorna Biotherapeutics, Inc, an immune-oncology drug and viral vaccine development company with both proprietary self-replicating mRNA and...